| Title |
Author |
Type |
Date |
Words |
| Elcelyx Therapeutics completes $20 million Series C financing. |
|
Brief article |
Apr 1, 2013 |
139 |
| Heart Genomics Receives Loan Funding from Institute for Commercialization of Public Research. |
|
|
Feb 8, 2013 |
586 |
| Invictus Foundation(TM) Receives Grant from Genentech, a Member of the Roche Group. |
|
|
Jan 23, 2013 |
641 |
| Solazyme Bunge Renewable Oils Joint Venture Receives Funding Approval from Brazilian Development Bank. |
|
|
Jan 17, 2013 |
1089 |
| Canada : Versartis closes $25 million series C financing. |
|
|
Jan 16, 2013 |
344 |
| ADMA Biologics Secures Up To $6 Million Term Loan Commitment To Advance Phase III Study. |
|
|
Jan 7, 2013 |
761 |
| 23andMe Raises More Than $50 Million in New Financing. |
|
|
Dec 11, 2012 |
550 |
| AGTC Secures $37.5M Series B Funding. |
|
|
Nov 19, 2012 |
883 |
| Compugen Announces $15 Million Funding Agreement for Its Keddem Subsidiary. |
|
|
Nov 19, 2012 |
1138 |
| Ziarco Secures Series A Funding. |
|
|
Nov 5, 2012 |
811 |
| Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation. |
|
|
Oct 16, 2012 |
491 |
| RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology. |
|
|
Oct 4, 2012 |
896 |
| HemoShear Closes a $1MM Debt Financing Round to Support Continued Expansion. |
|
|
Sep 26, 2012 |
618 |
| Austria : Arsanis expands its anti-infective monoclonal antibody programs with additional grant support from FFG and EUROSTARS. |
|
|
Sep 11, 2012 |
364 |
| Arsanis Expands Its Anti-Infective Monoclonal Antibody Programs with Additional Grant Support from FFG and EUROSTARS. |
|
|
Sep 10, 2012 |
642 |
| United States : CORONADO BIOSCIENCES gets US $15 million secured loan facility. |
|
Brief article |
Sep 2, 2012 |
128 |
| Global MSL Team Budgets Top $30 Million, Finds Cutting Edge Information. |
|
|
Aug 15, 2012 |
452 |
| GE Capital is Administrative Agent on $100 Million Senior Credit Facility for Affymetrix, Inc. |
|
|
Jul 9, 2012 |
400 |
| Do investors care about earnings management? |
Latif, Saira; Yang, Yi |
Report |
Jun 22, 2012 |
5239 |
| Taiwan Medtech fund may fail to complete fund raising. |
Liu, Philip |
|
Jun 12, 2012 |
380 |
| PhaseBio Pharmaceuticals Received an Additional $23 Million With Completion of the Third Tranche of a Series B Financing For Advancement of Metabolic and Cardiovascular Product Portfolio. |
|
|
Jun 5, 2012 |
540 |
| Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses. |
|
|
May 9, 2012 |
1094 |
| Profectus BioSciences Receives NIAID Grant to Develop a Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses. |
|
|
May 2, 2012 |
904 |
| LabCorp[R] Enters into New Credit Facility Totaling $1.0 Billion. |
|
|
Dec 21, 2011 |
572 |
| Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round. |
|
|
Dec 20, 2011 |
815 |
| Profectus BioSciences, Inc. Receives $5.4M Grant to Develop a Monocolonal Antibody Against Infection by Nipah/Hendra Viruses. |
|
|
Dec 13, 2011 |
769 |
| Amarantus BioSciences Receives Grant from Brewer Sports International for Traumatic Brain Injury. |
|
|
Nov 30, 2011 |
900 |
| Prolacta Bioscience[R] Secures Series D Funding from Health Evolution Partners. |
|
|
Nov 3, 2011 |
1083 |
| Semprus BioSciences receives million-dollar grant to develop bacteria-resistant trauma implants. |
|
|
Nov 1, 2011 |
603 |
| Arteaus Therapeutics, LLC Raises $18M to Prevent Migraines. |
|
|
Oct 19, 2011 |
913 |
| Arsanis Receives Grant from the Austrian Research Promotion Agency for Pre-Clinical and Clinical Development of Monoclonal Antibodies Against Severe Nosocomial Infections. |
|
|
Oct 19, 2011 |
505 |
| Cutting Edge Information Finds Country-Level Medical Affairs Budgets Now Average $1.9 Million. |
|
|
Oct 13, 2011 |
452 |
| Pharmaceutical Competitive Intelligence Budgets Grow 62%. |
|
|
Oct 11, 2011 |
458 |
| AGTC Receives Grant from the Foundation Fighting Blindness for Pre-Clinical Study of Gene Therapy for Eye Disease. |
|
|
Sep 21, 2011 |
912 |
| Investigator Initiated Trial Budgets up 21%, Finds New Study. |
|
|
Sep 13, 2011 |
460 |
| Diamyd Medical: Diamyd Awarded Three Million Dollar Grant and Expands the NTTDS Portfolio. |
|
|
Sep 12, 2011 |
1105 |
| TMF will raise NT$5 b. fund by year end. |
Liu, Philip |
|
Aug 17, 2011 |
316 |
| Redwood Bioscience Secures Funding for Optimized Conjugate Drug Development. |
|
|
Jun 27, 2011 |
900 |
| Sequenom Enters Into New $30.0 Million Credit Facility. |
|
|
Jun 2, 2011 |
1127 |
| Burrill & Co. pledges US$30m. investment in Taiwan's biotech industry. |
Liu, Ken |
|
May 31, 2011 |
283 |
| Ma designates biotech as Taiwan's next pivotal industry. |
Liu, Ken |
Brief article |
May 19, 2011 |
250 |
| ACADIA Pharmaceuticals Awarded Grant from National Institutes of Health for the Development of Novel ER-beta Agonists. |
|
|
May 17, 2011 |
851 |
| RXi Pharmaceuticals and the University of Massachusetts Medical School Announce Massachusetts Life Sciences Center Cooperative Research Grant for RNAi Therapeutics for ALS. |
|
|
Apr 28, 2011 |
1209 |
| 4 Small Businesses Awarded Scholarships to Attend International Biotechnology Convention, Other Funds Still Available. |
|
|
Apr 25, 2011 |
622 |
| KellBenx Secures $2.5 Million Funding Round. |
|
|
Apr 21, 2011 |
343 |
| Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio. |
|
|
Mar 7, 2011 |
1243 |
| GE Capital Provides $12.5 Million Senior Secured Multi-Draw Term Loan Facility to Oncothyreon Inc. |
|
|
Feb 10, 2011 |
390 |
| Commonwealth Biotechnologies, Inc. Announces Filing for Reorganization Under Chapter 11 Bankruptcy. |
|
|
Jan 21, 2011 |
373 |
| MabCure Secures $10 Million Funding Commitment from an Institutional Investor Managed by Roswell Capital Partners. |
|
|
Jan 20, 2011 |
668 |
| DBV Technologies closes $25.5 ([euro]19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ventures, Shire plc, and ALTO Invest; as well as existing investors Sofinnova Partners and ALK Abello. |
|
|
Jan 5, 2011 |
891 |
| Advanced Cell Technology Secures $25 Million Funding Commitment. |
|
|
Dec 31, 2010 |
802 |
| Longwood Launches First Fund. |
|
Company overview |
Dec 27, 2010 |
498 |
| 'New' lenders ante up $175M for lab loan. |
|
|
Dec 8, 2010 |
258 |
| Funds shortfall stymies biotech incubator plan. |
|
|
Dec 1, 2010 |
416 |
| Agenta Receives $1.1 Million NIH-SBIR Grant to Develop Novel Skin Healing and Regeneration Technology. |
|
|
Nov 11, 2010 |
506 |
| Northwest Biotherapeutics Receives Two 'Qualified Therapeutic Discovery Project' Grants. |
|
|
Nov 4, 2010 |
903 |
| ImmunoCellular Therapeutics Receives $244,479 Grant Under the Patent Protection and Affordable Care Program. |
|
|
Nov 4, 2010 |
650 |
| Emergent BioSolutions Receives Loan Repayment from Protein Sciences Corporation. |
|
|
Nov 3, 2010 |
162 |
| Bio-Path Holdings Awarded Grant from the U.S. Government's Qualifying Therapeutic Discovery Project Program. |
|
|
Nov 3, 2010 |
669 |
| Expression Analysis and Illumina Fund GWAS and Data Analysis Grant Program to Support Cancer Research. |
|
|
Nov 2, 2010 |
724 |
| Benitec Limited (ASX:BLT) Cash Flow Update For The Quarter Ended 30 September 2010. |
|
|
Oct 29, 2010 |
305 |
| NOXXON Confirms Total Capital Raise of [euro]35m. |
|
|
Oct 12, 2010 |
410 |
| AGTC Receives Second Grant from Food and Drug Administration for Clinical Study of Genetic Respiratory Disease. |
|
Clinical report |
Sep 16, 2010 |
771 |
| Q Chip raises pounds 2m in funding round to boost production. |
|
|
Sep 16, 2010 |
284 |
| AGTC Receives Grant from Food and Drug Administration for Clinical Study of Genetic Retinal Disease. |
|
Clinical report |
Sep 13, 2010 |
860 |
| Taligen Closes $10 Million Series B Financing Tranche. |
|
|
Aug 23, 2010 |
368 |
| HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing. |
|
|
Jul 28, 2010 |
457 |
| United States : Chiasma collects $2M in debt financing. |
|
|
Jul 25, 2010 |
180 |
| Belgian Ablynx gets R&D funding. |
|
|
Jul 6, 2010 |
115 |
| Expert urges gov't to step up formation of NT$60b. biotech fund. |
Liu, Philip |
|
Jul 5, 2010 |
389 |
| Creative financing: the SEDA, a financial "bridge" for biotechs. |
Nowak, Mike |
Report |
Jul 1, 2010 |
1746 |
| Biotechnology company Exelixis Inc (South San Francisco CA) said Thursday it entered two financing deals for a combined $160 million. |
|
|
Jun 7, 2010 |
152 |
| Exelixis to Raise $160 Million through Financing Transactions with Silicon Valley Bank and Deerfield Management. |
|
|
Jun 3, 2010 |
974 |
| Biotech company nets vital funding. |
|
|
Jun 3, 2010 |
367 |
| PolyMedix Receives National Science Foundation Grant to Support Development of Antimicrobial Sutures. |
|
|
May 27, 2010 |
865 |
| NOXXON Pharma AG raises [euro]33 million in Series D Round. |
|
|
May 27, 2010 |
1088 |
| Phage Pharmaceuticals Launched -- Receives Funding for Purchase of Assets. |
|
|
May 24, 2010 |
473 |
| BIO Asks Congress to Fund GREEN JOB Act. |
|
|
May 18, 2010 |
781 |
| Viral Genetics Opens Lab in Texas: Lead Scientist Awarded $750,000 Grant. |
|
|
Apr 19, 2010 |
1018 |
| SiDMAP Chief Scientist to Collaborate on Cancer Research Grant with Johns Hopkins School of Medicine. |
|
|
Apr 6, 2010 |
497 |
| PolyMedix Secures $14 Million Credit Facility and Files Shelf Registration Statement. |
|
|
Apr 1, 2010 |
1085 |
| Amyris Biotechnologies Secures Investment from Temasek Holdings. |
|
|
Mar 31, 2010 |
252 |
| Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma. |
|
|
Mar 29, 2010 |
843 |
| Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy. |
|
|
Mar 2, 2010 |
783 |
| Austrian Sanochemia sends AlcaSynn into insolvency. |
|
|
Feb 19, 2010 |
140 |
| Advaxis Closes Second Company-Run Debt Financing. |
|
|
Oct 28, 2009 |
526 |
| TechnoVax Receives $2.9 Million Grant for Flu and Influenza Virus-Like Particle (VLP) Vaccine Program. |
|
|
Oct 20, 2009 |
371 |
| Biotech fundraising rises amid vaccine hype, cash need. |
|
Brief article |
Oct 12, 2009 |
313 |
| Bio-Clean International Secures $300,000 Investment. |
|
|
Oct 9, 2009 |
634 |
| Amyris Secures Funding to Advance Scale Up, First Commercial Plant. |
|
|
Oct 1, 2009 |
823 |
| Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science. |
|
|
Sep 29, 2009 |
550 |
| Advaxis Secures $5.0 Million Investment. |
|
|
Sep 25, 2009 |
799 |
| An innovative financing tool for biotech: facing one of the most severe market downturns in recent decades, growing and developing biotech companies need to be creative when accessing capital. An innovative financing tool, pioneered by a US fund, has provided a useful alternative for European biotech companies to complement their financing strategies. |
|
|
Sep 1, 2009 |
1527 |
| Tech startup of the month: company OPX Biotechnologies Inc. |
Peterson, Eric |
|
Aug 1, 2009 |
556 |
| Israeli drug-development company BiolineRX said that Ikaria Holdings Inc (Clinton NJ) had agreed to pay $285 million for a license to develop and market its BL-1040 drug for heart attack patients. |
|
Brief article |
Jul 13, 2009 |
137 |
| Nanogen Completes Asset Sale. |
|
|
Jul 8, 2009 |
417 |
| Compugen Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic Candidates. |
|
|
Jun 24, 2009 |
607 |
| Advaxis Completes Debt Financing. |
|
|
Jun 18, 2009 |
561 |
| PolyMedix Receives $923,000 SBIR Grant to Support Development of LMWH Antagonists. |
|
|
Jun 12, 2009 |
747 |
| UBS says Bristol-Myers not in talks for Elan Stake. |
|
Brief article |
Jun 8, 2009 |
167 |
| Compugen Awarded Grants From Israel Office of Chief Scientist. |
|
|
Jun 3, 2009 |
601 |
| PolyMedix Secures $10 Million Equity Line Facility with Dutchess Equity Fund, LP. |
|
|
May 20, 2009 |
794 |
| Biotechnology companies struggling with funding shortages because of the global credit crisis will be scrambling later this month for the attention of cash-rich drugmakers at the world's largest annual meeting of cancer doctors. |
|
|
May 18, 2009 |
468 |
| E&Y report says biotechs running out of funding options. |
|
|
May 11, 2009 |
341 |
| SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business. |
|
|
Apr 23, 2009 |
1054 |
| Viral Genetics Successfully Secures Grant for New Lyme Research Study. |
|
|
Mar 18, 2009 |
908 |
| Advanced Cell Technology Secures $5 Million Credit Facility to Develop RPE Program for the Treatment of Diseases of the Eye. |
|
|
Mar 11, 2009 |
1033 |
| Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma. |
|
|
Mar 2, 2009 |
805 |
| Heptares Therapeutics Ltd., a two-year-old British biotech company, has raised 21 million pounds ($30.6 million) in private equity finance from Swiss drug giant Novartis AG and two venture capital firms. |
|
Brief article |
Mar 2, 2009 |
132 |
| AC Immune SA. |
|
Brief article |
Feb 2, 2009 |
213 |
| Hydra Biosciences Raises $22 Million in Series D Financing. |
|
|
Jan 16, 2009 |
461 |
| Biotechnology could lose 100 public companies in 2009. |
|
|
Jan 12, 2009 |
356 |
| INNEXUS BIOTECHNOLOGY GETS PATENT GRANTS IN EUROPE. |
|
|
Dec 1, 2008 |
300 |
| Financing Sector: the global economic crisis has cut funding for biotechnology companies to the lowest level in a decade, triggering bankruptcies and threatening development of drugs based on biomedical breakthroughs. |
|
|
Nov 24, 2008 |
329 |
| InNexus Biotechnology Receives Patent Grants in Europe. |
|
|
Oct 30, 2008 |
477 |
| Major cash injection for firm at forefront of Alzheimer's fight; Alzeim looking to expand production of daffodil drug. |
|
|
Oct 29, 2008 |
650 |
| Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition. |
|
|
Sep 26, 2008 |
719 |
| Emergent BioSolutions Initiates Lawsuit Against Protein Sciences and Its Senior Management Regarding Delayed Asset Acquisition. |
|
|
Jul 9, 2008 |
715 |
| EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National Institutes of Health. |
|
|
Jul 8, 2008 |
1079 |
| Symphogen S/A. |
|
Brief article |
Jun 16, 2008 |
101 |
| Instrument companies' extraordinary charges. |
|
|
Apr 15, 2008 |
1226 |
| NOXXON Receives Research Grant from the Federal Ministry of Education and Research. |
|
|
Apr 7, 2008 |
187 |
| Expression Pathology Obtains Maryland Funding to Develop Breast Cancer Test. |
|
|
Feb 7, 2008 |
376 |
| Arcion Therapeutics Raises $8.8 Million "A" Round. |
|
|
Jan 9, 2008 |
591 |
| Protagen raises 1 million [euro]. |
|
Brief article |
Jan 1, 2008 |
166 |
| Neurologix Receives Grant from the Epilepsy Research Foundation for Gene Transfer Research. |
|
|
Dec 4, 2007 |
1181 |
| Research and Markets: the New Generex Biotechnology Corporation Latest Product Pipeline Report Contains Contact Information, Business Summary, Company Details and Selected Financial Data. |
|
Report |
Nov 8, 2007 |
240 |
| LEAD Therapeutics Raises $17 Million in Series A Financing. |
|
|
Nov 5, 2007 |
842 |
| Japan. |
|
Brief article |
Oct 31, 2007 |
173 |
| AVI BioPharma Receives Major Research and Development Grant From Charley's Fund for Duchenne Muscular Dystrophy. |
|
|
Oct 15, 2007 |
1063 |
| Health Discovery Corporation's Private Equity Offering Oversubscribed. |
|
|
Oct 4, 2007 |
452 |
| Panacos Secures $20 Million Debt Financing. |
|
|
Jun 28, 2007 |
562 |
| Pluristem Receives $830,000 Grant from Israeli Government for Development of the PLX-I Stem Cell Product. |
|
|
May 31, 2007 |
651 |
| Pluristem Closes on $13.5 Million Private Equity Investment. |
|
|
May 22, 2007 |
690 |
| Pasteuria Bioscience Raises $5.3M in Series B. |
|
Company overview |
May 4, 2007 |
377 |
| ECI Biotech receives small-business grant; $299,066 will aid periodontal work. |
|
|
Feb 13, 2007 |
170 |
| Pluristem Receives $470,000 Grant from Israeli Government to Further Develop PLX-I Stem Cell Product. |
|
|
Aug 24, 2006 |
804 |
| The bottom line: data from recent industry financial reports. Dollar amounts in millions. |
|
Statistical table |
Jul 31, 2006 |
447 |
| Advanced Cell Technology Applauds Governor Schwarzenegger for Directing $150 Million Loan to Fund Stem Cell Research; Further Positions California as World Leader in Field of Regenerative Medicine. |
|
|
Jul 21, 2006 |
493 |
| SFBC International Provides Update on Miami Operations; Company Also Receives Waivers for Credit Facility. |
|
|
Jun 29, 2006 |
771 |
| Adnexus Therapeutics Closes $27M Series B Funding; Series B Financing Led by Venrock will Advance Breakthrough New Product Class, AdNectins. |
|
|
Jun 26, 2006 |
840 |
| SFBC International Comments on Moody's Debt Ratings Action. |
|
|
Apr 12, 2006 |
724 |
| SFBC International Granted Waivers for Credit Facility. |
|
|
Mar 29, 2006 |
776 |
| Nabi Biopharmaceuticals granted Fast Track Designation by FDA for Civacir to prevent HCV re-infection in liver transplant patients. |
Rathjen, Thomas |
Brief Article |
Feb 28, 2006 |
194 |
| INTEGRA LIFESCIENCES ESTABLISHES $200 MIL. CREDIT. |
|
Brief Article |
Feb 1, 2006 |
250 |
| Lifeline Biotechnologies Reduces Debt By $250,000. |
|
|
Dec 7, 2005 |
455 |
| U.S. Microbics Engages Oaktree Ventures, Inc. for Capital Formation; Funds for Mexico Operations and Agricultural Growth Products. |
|
|
Dec 2, 2005 |
447 |
| Vital Therapies Completes First Closing of $8 Million Private Equity Financing. |
|
|
Nov 1, 2005 |
823 |
| US Government $20M NIAID Grant Funds Proteome Systems' ''Catalytic Scavenger Compounds'' to Treat Radiation Damage in Humans Caused by Terrorist Attacks or Industrial Accidents; PSL Invited to Present at Prestigious BIO Investor Forum. |
|
|
Oct 20, 2005 |
650 |
| Aerie Pharmaceuticals Announces $21 Million Series A Financing; Company to Develop Innovative Products for Treatment of Glaucoma. |
|
|
Oct 12, 2005 |
881 |
| GenPat77 Receives BMBF Grant to Accelerate Development of CEACAM1 Into Clinical Trials. |
|
|
Oct 11, 2005 |
463 |
| Hercules Provides $7.5M Financing to Predicant Biosciences. |
|
|
Oct 11, 2005 |
496 |
| VIRxSYS Completes $30 Million Financing. |
|
|
Oct 11, 2005 |
817 |
| Bolder BioTechnology Awarded NIH Phase I SBIR Grant to Develop Bioscavenger Protein for Detoxifying Nerve Agents. |
|
|
Oct 10, 2005 |
334 |
| Serenex Raises $30 Million in Series C Financing. |
|
|
Oct 6, 2005 |
699 |
| Minotaur awarded SBTT Grant. |
|
Brief Article |
Jul 4, 2005 |
155 |
| Human Genome Sciences receives milestone payments from GlaxoSmithKline for GSK716155 progress. |
|
|
Jul 1, 2005 |
366 |
| CRUCELL REPORTS 2004 THREE-FOLD INCREASE OVER 2003 REVENUE. |
|
|
Mar 1, 2005 |
2190 |
| Life support: the network helping to boost Indiana's life-sciences industry. |
Kaelble, Steve |
|
Jan 1, 2005 |
1341 |
| Biotechnology. |
|
Brief Article |
Dec 15, 2004 |
102 |
| India. |
|
|
Dec 15, 2004 |
101 |
| ECI BIOTECH OF WORCESTER AWARDED NATIONAL EYE INSTITUTE GRANT. |
|
|
Aug 1, 2004 |
2614 |
| Monsanto sponsors GMO Swedish lager. |
|
|
Jul 19, 2004 |
863 |
| WellGen receives investment from Amphion Capital Partners. |
|
Brief Article |
May 1, 2004 |
155 |
| MEDMIRA REPORTS 2ND QTR NET LOSS OF $996 THOUSAND. |
|
|
May 1, 2004 |
523 |
| Biotechnology. |
|
Brief Article |
Apr 30, 2004 |
151 |
| MEDIMMUNE PLANS TO ACHIEVE $2 BILLION IN REVENUES BY 2009. |
|
|
Apr 1, 2004 |
1383 |
| Value creation in the biotechnology industry; as a recent study demonstrates, it's non-financial disclosures that are key to value creation in this and other growing industries. Understand an industry's value drivers and you'll better understand the potential of individual firms. |
McConomy, Bruce; Xu, Bixia |
|
Apr 1, 2004 |
2127 |
| BIOXEL PHARMA REPORTS NET LOSS OF $3.5 MILLION FOR 9 MONTHS. |
|
Company Profile |
Jan 1, 2004 |
1082 |
| Life Science Sales Index: operating margins improve in Q3. |
|
Editorial |
Dec 15, 2003 |
1360 |
| ICON REPORTS 47% INCREASE IN REVENUES FOR 1ST QTR FY 2004. |
|
|
Nov 1, 2003 |
555 |
| PARALLELE BIOSCIENCE SECURES $22.5 MILLION IN FINANCING. |
|
|
Nov 1, 2003 |
445 |
| GENSCI REPORTS DECREASE IN NET LOSS FOR 2ND QTR '03. |
|
|
Oct 1, 2003 |
581 |
| PERKINELMER REPORTS 2ND QTR '03 REVENUE DOWN 2% FROM 2002. |
|
|
Sep 1, 2003 |
1109 |
| Amersham Biosciences. |
|
|
Aug 31, 2003 |
481 |
| Aastrom Biosciences receives NIH grant to expand development of cell-base approaches for bone regeneration. |
|
Brief Article |
Jul 11, 2003 |
239 |
| MWG Biotech reported a 6.6% decline in sales for the first quarter to 11.4 million [euro] ($12.3 million = 0.93 [euro] = $1) (see IBO 5/31/03). (Organizational news: company announcements). |
|
Brief Article |
Jun 15, 2003 |
82 |
| Making the case for ag biotech investment. (Investing). |
Steen, Tom |
|
Jun 1, 2003 |
751 |
| Amersham Biosciences. |
|
Brief Article |
May 31, 2003 |
193 |
| Life Science sales show mixed results. |
|
|
May 31, 2003 |
590 |
| Affymetrix lowers first quarter forecast. (Executive briefing: news, trends & market intelligence for instrument executives). |
|
Brief Article |
Apr 15, 2003 |
116 |
| HYCOR REPORTS INCREASE IN 4TH QTR AND YEAR-END PROFIT. |
|
|
Apr 1, 2003 |
477 |
| APPLIED BIOSYSTEMS REPORTS $29.9 MILLION NET INCOME 2ND QTR. |
|
|
Mar 1, 2003 |
1216 |
| Around the province. |
|
|
Mar 1, 2003 |
519 |
| Amersham Biosciences. |
|
|
Feb 28, 2003 |
381 |
| January strikes sour note for stocks. |
|
|
Jan 31, 2003 |
3499 |
| Korea. (Region Watch). |
|
Brief Article |
Jan 31, 2003 |
99 |
| Organ Recovery Systems receives $14 million in financing from variety of previous institutional investors. |
|
Brief Article |
Jan 31, 2003 |
190 |
| Life science and government spending lift prospects. |
|
|
Jan 15, 2003 |
1058 |
| BioLife Solutions awarded SBIR grant from NIH. |
|
|
Dec 9, 2002 |
251 |
| IMMUCELL RETURNS TO PROFITABILITY. |
|
|
Dec 1, 2002 |
531 |
| IDEXX REPORTS 3RD QTR NET INCOME INCREASED 22%. |
|
|
Dec 1, 2002 |
472 |
| The bottom line. |
|
|
Oct 15, 2002 |
434 |
| Life sciences industry outlook. |
|
Panel Discussion |
Oct 1, 2002 |
4383 |
| EPOCH BIOSCIENCES REPORTS INCREASED FIRST QTR. REVENUES. |
|
Brief Article |
Jun 1, 2002 |
948 |
| EXACT SCIENCES REPORTS NET LOSS OF 7.6 MILLION FOR FIRST QTR. |
|
Brief Article |
Jun 1, 2002 |
647 |
| Hybridon Announces Third Quarter Results. |
|
|
Nov 15, 2001 |
747 |
| NeoTherapeutics Reports 55% Improvement in Third Quarter Financial Results. |
|
|
Nov 14, 2001 |
1545 |
| Orchid BioSciences, Inc. Reports Third Quarter Financial Results. |
|
|
Nov 13, 2001 |
3043 |
| ThermoGenesis Corp. Announces First Quarter Results. |
|
|
Nov 13, 2001 |
818 |
| Maxygen Reports Strong Third Quarter 2001 Financial and Operating Results. |
|
|
Nov 13, 2001 |
1690 |
| Genelabs Technologies, Inc. Reports Third Quarter and Nine Month 2001 Financial Results. |
|
|
Nov 13, 2001 |
1760 |
| Orchid BioSciences, Inc. Reports Third Quarter Financial Results. |
|
|
Nov 8, 2001 |
3043 |
| Trimeris Announces Third Quarter 2001 Results. |
|
|
Nov 8, 2001 |
903 |
| Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2002. |
|
|
Nov 7, 2001 |
1007 |
| Paradigm Genetics announces Third Quarter Financial Results, Revenues Increase 77%. |
|
|
Nov 7, 2001 |
1871 |
| Neurocrine Biosciences Reports Positive Third Quarter 2001 Results; Neurocrine Awarded SBIR Grant From NIH for GnRH Antagonist Program. |
|
|
Nov 1, 2001 |
1461 |
| Transgenomic, Inc. Reports Record Third Quarter Revenues. |
|
|
Oct 31, 2001 |
1547 |
| BioMarin Announces Third Quarter 2001 Financial Results. |
|
|
Oct 26, 2001 |
1139 |
| Incyte Genomics Reports Record Revenues for Third Quarter 2001. |
|
|
Oct 25, 2001 |
2210 |
| Human Genome Sciences Reports Financial Results for Third Quarter of 2001. |
|
|
Oct 25, 2001 |
2409 |
| Affymetrix Reports Third Quarter Results. |
|
|
Oct 24, 2001 |
1876 |
| Genzyme Transgenics Reports Third Quarter 2001 Financial Results. |
|
|
Oct 22, 2001 |
902 |
| ArQule, Inc. Reports Financial Results for Third Quarter Ended September 30, 2001. |
|
|
Oct 18, 2001 |
1185 |
| Genzyme General Reports 33 Percent Increase In Third-Quarter Revenues. |
|
|
Oct 18, 2001 |
4667 |
| Genzyme Biosurgery Reports Continued Revenue Growth in Third Quarter. |
|
|
Oct 18, 2001 |
4113 |
| Genzyme Molecular Oncology Reports Third Quarter 2001 Results. |
|
|
Oct 18, 2001 |
2887 |
| Sangamo BioSciences Reports Third-Quarter Financial Results. |
|
|
Oct 18, 2001 |
1344 |
| Millennium Reports Third Quarter 2001 Financial Results. |
|
|
Oct 16, 2001 |
2915 |
| SFBC INTERNATIONAL SEES CONTINUED GROWTH IN SALES/EARNINGS. |
|
Brief Article |
Oct 1, 2001 |
445 |
| Thermogenesis Corp. Announces Fiscal Year 2001 Results. |
|
|
Sep 27, 2001 |
1292 |
| Orchid Reaffirms Third Quarter Forecasts. |
|
|
Sep 18, 2001 |
787 |
| Genzyme Transgenics Updates Expectations and Announces September 10, 2001 Conference Call. |
|
|
Sep 7, 2001 |
440 |
| DIACRIN REPORTS 2ND QTR NET LOSS OF $1.3 MILLION. |
|
Brief Article |
Sep 1, 2001 |
292 |
| U. S. Microbics Reports Record-Breaking Nine Month Results. |
|
|
Aug 22, 2001 |
611 |
| NeoTherapeutics Reports 46 Percent Improvement In Second Quarter Financial Results. |
|
|
Aug 14, 2001 |
1482 |
| Maxygen Reports Second Quarter 2001 Financial Results. |
|
|
Aug 14, 2001 |
1145 |
| Genelabs Technologies, Inc. Reports Second Quarter and Six Month 2001 Financial Results. |
|
|
Aug 13, 2001 |
1261 |
| Trimeris Announces Second Quarter 2001 Results. |
|
|
Aug 9, 2001 |
845 |
| Orchid BioSciences, Inc. Reports Second Quarter Financial Results. |
|
|
Aug 7, 2001 |
2724 |
| TriPath Imaging Announces Agreement to Develop Molecular Cancer Diagnostics with BD. |
|
|
Aug 2, 2001 |
1827 |
| Transgenomic, Inc. Reports Record Second Quarter Revenues. |
|
|
Aug 1, 2001 |
1473 |
| Paradigm Genetics Announces Second Quarter Financial Results, Revenues Increase 257%. |
|
|
Aug 1, 2001 |
1578 |
| Neurocrine Biosciences Reports Second Quarter 2001 Results; Company Expands Clinical Development Efforts. |
|
|
Jul 31, 2001 |
1669 |
| BioMarin Announces Second Quarter 2001 Financial Results. |
|
|
Jul 27, 2001 |
1220 |
| Invitrogen Announces Second Quarter 2001 Results And Executive and Board Changes. |
|
|
Jul 26, 2001 |
4158 |
| Human Genome Sciences Reports Financial Results for Second Quarter of 2001. |
|
|
Jul 26, 2001 |
2993 |
| Affymetrix Reports Second Quarter Results. |
|
|
Jul 25, 2001 |
1846 |
| BioVentures Sees First Business Graduate. |
Friedman, Mark |
Brief Article |
Jul 23, 2001 |
165 |
| Genzyme Transgenics Reports Second Quarter 2001 Financial Results. |
|
|
Jul 19, 2001 |
877 |
| Genzyme General Reports 28 Percent Increase in Second-Quarter Revenues. |
|
|
Jul 19, 2001 |
5007 |
| Genzyme Biosurgery Reports Second Quarter Results. |
|
|
Jul 19, 2001 |
4084 |
| Genzyme Molecular Oncology Reports Second Quarter 2001 Results. |
|
|
Jul 19, 2001 |
2837 |
| Sangamo BioSciences Reports Second-Quarter Financial Results. |
|
|
Jul 19, 2001 |
1437 |
| Incyte Reports Financial Results for Second Quarter of Fiscal 2001 With Revenues Up 22%, Its Fifth Consecutive Quarter of Double-Digit Sales Growth. |
|
|
Jul 19, 2001 |
1342 |
| ArQule, Inc. Reports Financial Results for Second Quarter Ended June 30, 2001. |
|
|
Jul 17, 2001 |
1191 |
| Millennium Reports Second Quarter 2001 Financial Results. |
|
|
Jul 17, 2001 |
2785 |
| Maxygen Announces Improved Financial Outlook. |
|
|
Jul 12, 2001 |
415 |
| Trimeris Announces First Quarter 2001 Results. |
|
|
May 11, 2001 |
755 |
| Maxygen Reports First Quarter 2001 Financial Results. |
|
|
May 8, 2001 |
1639 |
| Human Genome Sciences Reports Financial Results for First Quarter of 2001. |
|
|
Apr 27, 2001 |
2135 |
| Sangamo BioSciences Reports First-Quarter Financial Results. |
|
|
Apr 25, 2001 |
1266 |
| Affymetrix Reports First Quarter Results. |
|
|
Apr 25, 2001 |
2346 |
| Incyte Reports Financial Results for First Quarter of Fiscal 2001 Revenues Up 25%. |
|
|
Apr 25, 2001 |
1270 |
| Genzyme Transgenics Reports First Quarter 2001 Financial Results. |
|
|
Apr 20, 2001 |
920 |
| ArQule, Inc. Reports Financial Results for First Quarter Ended March 31, 2001. |
|
|
Apr 19, 2001 |
1114 |
| Genzyme General's Revenues Increase 25 Percent in First Quarter. |
|
|
Apr 19, 2001 |
4238 |
| Genzyme Molecular Oncology Reports First Quarter 2001 Financial Results. |
|
|
Apr 19, 2001 |
1988 |
| ArQule, Inc. to Report First Quarter Financial Results on April 19, 2001. |
|
|
Apr 12, 2001 |
374 |
| Millennium to Webcast Conference Call on First Quarter 2001 Financial Results on April 18, 2001. |
|
|
Apr 11, 2001 |
211 |
| Genelabs Technologies, Inc. Reports 2000 Year End and Fourth Quarter Financial Results. |
|
|
Mar 29, 2001 |
1405 |
| Bionova Holding Announces 2000 Year-End Results and Litigation Update. |
|
|
Mar 6, 2001 |
1082 |
| CELERA GENOMICS REPORTS $20.3 MILLION 2ND QTR REVENUES. |
|
Brief Article |
Mar 1, 2001 |
1027 |
| Exelixis Announces Fourth Quarter and Year End Financial Results. |
|
|
Feb 28, 2001 |
1870 |
| Genset Reports Year End 2000 Financial Results. |
|
|
Feb 20, 2001 |
1645 |
| Select Therapeutics Announces Second Quarter 2001 Results. |
|
|
Feb 15, 2001 |
1029 |
| Trimeris Announces Fourth Quarter and Year-End 2000 Results. |
|
|
Feb 15, 2001 |
878 |
| Maxygen Reports Fourth Quarter and Year End 2000 Financial Results. |
|
|
Feb 13, 2001 |
1955 |
| MorphoSys Previews Year 2000 Revenues. |
|
|
Feb 8, 2001 |
645 |
| Paradigm Genetics Announces Year End 2000 Financial Results, Revenue Increases 371% Over 1999. |
|
|
Feb 8, 2001 |
1720 |
| Paradigm Genetics to Host Live Webcast of Fourth Quarter, Year-End 2000 Financial Results Conference Call. |
|
|
Feb 5, 2001 |
379 |
| Neurocrine Biosciences Announces the Webcast of Its Year End 2000 Earnings Release And Conference Call. |
|
|
Feb 1, 2001 |
326 |
| Incyte Reports Record Revenue of $194.2 Million for Fiscal Year 2000, Up 24% From Prior Year. |
|
|
Feb 1, 2001 |
1845 |
| Sangamo BioSciences Reports Fourth-Quarter and Year-End Financial Results. |
|
|
Feb 1, 2001 |
1169 |
| Millennium Reports Year End 2000 Financial Results - Provides 2001 Financial Guidance -. |
|
|
Jan 23, 2001 |
2431 |
| Demegen Reports Fiscal Year 2000 Results. |
|
|
Dec 18, 2000 |
538 |
| Maxygen Reports 2000 Third Quarter Financial Results. |
|
|
Nov 14, 2000 |
1601 |
| Genelabs Technologies, Inc. Reports Third Quarter And Nine Month 2000 Financial Results. |
|
|
Nov 14, 2000 |
1108 |
| Enchira Biotechnology Announces Third Quarter Earnings Report; Arbitration with Maxygen Commences. |
|
|
Nov 13, 2000 |
703 |
| Maxygen to Release Third Quarter 2000 Earnings on November 14, 2000. |
|
|
Nov 10, 2000 |
245 |
| Orchid BioSciences, Inc. Reports Third Quarter Financial Results. |
|
|
Nov 9, 2000 |
2137 |
| Exelixis Announces Third Quarter Financial Results. |
|
|
Nov 8, 2000 |
1501 |
| Human Genome Sciences Reports Third Quarter Financial Results. |
|
|
Nov 7, 2000 |
3220 |
| Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2001. |
|
|
Nov 2, 2000 |
907 |
| Trimeris Announces Third Quarter 2000 Results. |
|
|
Nov 1, 2000 |
765 |
| Paradigm Genetics Announces Third Quarter 2000 Financial Results, Revenue Increases 829% Over 1999. |
|
|
Nov 1, 2000 |
1530 |
| Invitrogen Corporation Announces Third Quarter Results. |
|
|
Nov 1, 2000 |
2244 |
| Transgenomic, Inc. Reports Record Third Quarter Revenues. |
|
|
Oct 31, 2000 |
1324 |
| BioMarin Announces Third Quarter 2000 Financial Results. |
|
|
Oct 30, 2000 |
1839 |
| Biomatrix Reports Third Quarter Financial Results. |
|
|
Oct 24, 2000 |
2014 |
| Trimeris Inc. Invites You to Join Its Third Quarter Conference Call on the Web. |
|
|
Oct 24, 2000 |
247 |
| Affymetrix Reports Profitable Quarter. |
|
|
Oct 24, 2000 |
1853 |
| Genset Reports Third Quarter 2000 Financial Results. |
|
|
Oct 23, 2000 |
1635 |
| Genzyme Corp. Reports Third-Quarter Financial Results For Genzyme Surgical Products. |
|
|
Oct 19, 2000 |
3341 |
| Genzyme Corp. Announces Genzyme Molecular Oncology's Third Quarter Financial Results. |
|
|
Oct 19, 2000 |
3589 |
| Genzyme Corp. Announces Third-Quarter Financial Results for Genzyme General. |
|
|
Oct 19, 2000 |
4785 |
| Genzyme Transgenics Reports Third Quarter 2000 Financial Results. |
|
|
Oct 18, 2000 |
1322 |
| Millennium Reports Third Quarter 2000 Financial Results. |
|
|
Oct 17, 2000 |
1847 |
| GelTex Pharmaceuticals Reports Third Quarter 2000 Results. |
|
|
Oct 17, 2000 |
1125 |
| Incyte Reports 47% Year-to-Year Increase in Third Quarter Revenue. |
|
|
Oct 17, 2000 |
1207 |
